• 1
    Canaris, G.J., Manowitz, N.R., Mayor, G. et al. (2000) The Colorado thyroid disease prevalence study. Archives of Internal Medicine, 160, 526534.
  • 2
    Parle, J.V., Franklyn, J.A., Cross, K.W. et al. (1993) Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. British Journal of General Practice, 43, 107109.
  • 3
    Somwaru, L.L., Arnold, A.M., Joshi, N. et al. (2009) High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. Journal of Clinical Endocrinology and Metabolism, 94, 13421345.
  • 4
    Hollowell, J.G., Staehling, N.W., Flanders, W.D. et al. (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism, 87, 489499.
  • 5
    Vadiveloo, T., Donnan, P.T., Cochrane, L. et al. (2011) The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 96, E1E8.
  • 6
    Wilson, S., Parle, J.V., Roberts, L.M. et al. (2006) Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. Journal of Clinical Endocrinology and Metabolism, 91, 48094816.
  • 7
    Meyerovitch, J., Rotman-Pikielny, P., Sherf, M. et al. (2007) Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Archives of Internal Medicine, 167, 15331538.
  • 8
    Parle, J.V., Franklyn, J.A., Cross, K.W. et al. (1991) Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clinical endocrinology (Oxford), 34, 7783.
  • 9
    Parle, J.V., Maisonneuve, P., Sheppard, M.C. et al. (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet, 358, 861865.
  • 10
    Biondi, B., Palmieri, E.A., Fazio, S. et al. (2000) Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism, 85, 47014705.
  • 11
    Roberts, L.M., Pattison, H., Roalfe, A. et al. (2006) Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Annals of Internal Medicine, 145, 573581.
  • 12
    Kalmijn, S., Mehta, K.M., Pols, H.A. et al. (2000) Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clinical endocrinology (Oxford), 53, 733737.
  • 13
    Van der Cammen, T.J., Mattace-Raso, F., Van, H.F. et al. (2003) Lack of association between thyroid disorders and Alzheimer's disease in older persons: a cross-sectional observational study in a geriatric outpatient population. Journal of the American Geriatrics Society, 51, 884.
  • 14
    Klein, I. & Ojamaa, K. (2001) Thyroid hormone and the cardiovascular system. New England Journal of Medicine, 344, 501509.
  • 15
    Pearce, E.N., Yang, Q., Benjamin, E.J. et al. (2010) Thyroid function and left ventricular structure and function in the Framingham Heart Study. Thyroid, 20, 369373.
  • 16
    Ching, G.W., Franklyn, J.A., Stallard, T.J. et al. (1996) Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart, 75, 363368.
  • 17
    Sawin, C.T., Geller, A., Wolf, P.A. et al. (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New England Journal of Medicine, 331, 12491252.
  • 18
    Auer, J., Scheibner, P., Mische, T. et al. (2001) Subclinical hyperthyroidism as a risk factor for atrial fibrillation. American Heart Journal, 142, 838842.
  • 19
    Cappola, A.R., Fried, L.P., Arnold, A.M. et al. (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA, 295, 10331041.
  • 20
    Gammage, M.D., Parle, J.V., Holder, R.L. et al. (2007) Association between serum free thyroxine concentration and atrial fibrillation. Archives of Internal Medicine, 167, 928934.
  • 21
    Brandt, F., Green, A., Hegedus, L. et al. (2011) A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. European Journal of Endocrinology, 165, 491497.
  • 22
    Thvilum, M., Brandt, F., Brix, T.H. et al. (2012) A review of the evidence for and against increased mortality in hypothyroidism. Nature Reviews. Endocrinology, 8, 417424.
  • 23
    Gussekloo, J., van Exel, E., de Craen, A.J. et al. (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA, 292, 25912599.
  • 24
    Collet, T.H., Gussekloo, J., Bauer, D.C. et al. (2012) Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Archives of Internal Medicine, 172, 799809.
  • 25
    Franklyn, J.A., Betteridge, J., Daykin, J. et al. (1992) Long-term thyroxine treatment and bone mineral density. Lancet, 340, 913.
  • 26
    Franklyn, J.A., Maisonneuve, P., Sheppard, M.C. et al. (1998) Mortality after the treatment of hyperthyroidism with radioactive iodine. New England Journal of Medicine, 338, 712718.
  • 27
    Faber, J. & Galloe, A.M. (1994) Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. European Journal of Endocrinology, 130, 350356.
  • 28
    Uzzan, B., Campos, J., Cucherat, M. et al. (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 81, 42784289.
  • 29
    Cummings, S.R., Nevitt, M.C., Browner, W.S. et al. (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. New England Journal of Medicine, 332, 767773.
  • 30
    Sheppard, M.C., Holder, R. & Franklyn, J.A. (2002) Levothyroxine treatment and occurrence of fracture of the hip. Archives of Internal Medicine, 162, 338343.
  • 31
    Bauer, D.C., Ettinger, B., Nevitt, M.C. et al. (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Annals of Internal Medicine, 134, 561568.
  • 32
    Lee, J.S., Buzkova, P., Fink, H.A. et al. (2010) Subclinical thyroid dysfunction and incident hip fracture in older adults. Archives of Internal Medicine, 170, 18761883.
  • 33
    Surks, M.I., Ortiz, E., Daniels, G.H. et al. (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA, 291, 228238.
  • 34
    Faber, J., Jensen, I.W., Petersen, L. et al. (1998) Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clinical endocrinology (Oxford), 48, 285290.
  • 35
    Sgarbi, J.A., Villaca, F.G., Garbeline, B. et al. (2003) The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. Journal of Clinical Endocrinology and Metabolism, 88, 16721677.
  • 36
    Helfand, M. & U.S. Preventive Services Task Force. (2004) Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. [Review] [87 refs]. Annals of Internal Medicine, 140, 128141.
  • 37
    Cooper, D.S. & Biondi, B. (2012) Subclinical thyroid disease. Lancet, 379, 11421154.
  • 38
    Tunbridge, W.M., Evered, D.C., Hall, R. et al. (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clinical endocrinology (Oxford), 7, 481493.
  • 39
    Boelaert, K., Syed, A.A., Manji, N. et al. (2009) Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism. Clinical endocrinology (Oxford), 70, 129138.
  • 40
    De Moraes, A.V., Pedro, A.B. & Romaldini, J.H. (2006) Spontaneous hypothyroidism in the follow up of Graves hyperthyroid patients treated with antithyroid drugs. Southern Medical Journal, 99, 10681072.
  • 41
    Boelaert, K., Newby, P.R., Simmonds, M.J. et al. (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. American Journal of Medicine, 123, 183189.
  • 42
    Lazarus, J.H. (2002) Epidemiology and prevention of thyroid disease in pregnancy. Thyroid, 12, 861865.
  • 43
    Gammage, M.D. & Franklyn, J.A. (1987) Amiodarone and the thyroid. The Quarterly journal of medicine, 62, 8386.
  • 44
    Vanderpump, M.P., Tunbridge, W.M., French, J.M. et al. (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical endocrinology (Oxford), 43, 5568.
  • 45
    Bell, R.J., Rivera-Woll, L., Davison, S.L. et al. (2007) Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clinical endocrinology (Oxford), 66, 548556.
  • 46
    Hueston, W.J. & Pearson, W.S. (2004) Subclinical hypothyroidism and the risk of hypercholesterolemia. Annals of family medicine, 2, 351355.
  • 47
    Owen, P.J., Rajiv, C., Vinereanu, D. et al. (2006) Subclinical hypothyroidism, arterial stiffness, and myocardial reserve. Journal of Clinical Endocrinology and Metabolism, 91, 21262132.
  • 48
    Hak, A.E., Pols, H.A., Visser, T.J. et al. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of Internal Medicine, 132, 270278.
  • 49
    McQuade, C., Skugor, M., Brennan, D.M. et al. (2011) Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid, 21, 837843.
  • 50
    Razvi, S., Weaver, J.U., Vanderpump, M.P. et al. (2010) The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. Journal of Clinical Endocrinology and Metabolism, 95, 17341740.
  • 51
    Boekholdt, S.M., Titan, S.M., Wiersinga, W.M. et al. (2010) Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clinical endocrinology (Oxford), 72, 404410.
  • 52
    Rodondi, N., den Elzen, W.P., Bauer, D.C. et al. (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA, 304, 13651374.
  • 53
    Rodondi, N., Newman, A.B., Vittinghoff, E. et al. (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Archives of Internal Medicine, 165, 24602466.
  • 54
    Rodondi, N., Bauer, D.C., Cappola, A.R. et al. (2008) Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. Journal of the American College of Cardiology, 52, 11521159.
  • 55
    Meier, C., Staub, J.J., Roth, C.B. et al. (2001) TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). Journal of Clinical Endocrinology and Metabolism, 86, 48604866.
  • 56
    Parle, J., Roberts, L., Wilson, S. et al. (2010) A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study. Journal of Clinical Endocrinology and Metabolism, 95, 36233632.
  • 57
    Danese, M.D., Ladenson, P.W., Meinert, C.L. et al. (2000) Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. Journal of Clinical Endocrinology and Metabolism, 85, 29933001.
  • 58
    Monzani, F., Caraccio, N., Kozakowa, M. et al. (2004) Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. Journal of Clinical Endocrinology and Metabolism, 89, 20992106.
  • 59
    Razvi, S., Ingoe, L., Keeka, G. et al. (2007) The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. Journal of Clinical Endocrinology and Metabolism, 92, 17151723.
  • 60
    Krassas, G.E., Poppe, K. & Glinoer, D. (2010) Thyroid function and human reproductive health. Endocrine Reviews, 31, 702755.
  • 61
    Thangaratinam, S., Tan, A., Knox, E. et al. (2011) Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ, 342, d2616.
  • 62
    Haddow, J.E., Palomaki, G.E., Allan, W.C. et al. (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine, 341, 549555.
  • 63
    Lazarus, J.H., Bestwick, J.P., Channon, S. et al. (2012) Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine, 366, 493501.
  • 64
    De Groot, L., Abalovich, M., Alexander, E.K. et al. (2012) Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 97, 25432565.
  • 65
    Stagnaro-Green, A., Abalovich, M., Alexander, E. et al. (2011) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid, 21, 10811125.